Telix Pharmaceuticals TLX
NASDAQ TLX
$11.93 +0.19 (+1.58%)
As of: Sep 4, 2026 · 1:37 PM EDT

Telix Pharmaceuticals (TLX) Assets Growth (1y) (2024 - 2025)

Analysis

Telix Pharmaceuticals (TLX) Assets Growth (1y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Telix Pharmaceuticals 4.03 Bn 3.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17.38%
Dec 31, 2024 275.25%